MLTX - MoonLake Immunotherapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MLTX is currently covered by 9 analysts with an average price target of $86.58. This is a potential upside of $33.31 (62.53%) from yesterday's end of day stock price of $53.27.

MoonLake Immunotherapeutics's activity chart (see below) currently has 42 price targets and 78 ratings on display. The stock rating distribution of MLTX is 97.92% BUY and 2.08% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 20.09% with an average time for these price targets to be met of 45.89 days.

Highest price target for MLTX is $100, Lowest price target is $66, average price target is $79.38.

Most recent stock forecast was given by RICHARD LAW from GOLDMAN SACHS on 06-Aug-2025. First documented stock forecast 21-Jul-2022.

Currently out of the existing stock ratings of MLTX, 47 are a BUY (97.92%), 1 are a HOLD (2.08%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$82

$29.38 (55.83%)

$73

1 months 10 days ago
(06-Aug-2025)

0/4 (0%)

$29.24 (55.42%)

Buy

$66

$13.38 (25.43%)

$66

4 months 3 days ago
(13-May-2025)

0/13 (0%)

$27.46 (71.25%)

Buy

$100

$47.38 (90.04%)

$100

6 months 20 days ago
(27-Feb-2025)

8/27 (29.63%)

$57.63 (136.02%)

86

Buy

11 months 24 days ago
(23-Sep-2024)

3/7 (42.86%)

$37.82 (94.13%)

35

Buy

$104

$51.38 (97.64%)

$92

1 years 2 months 22 days ago
(25-Jun-2024)

1/12 (8.33%)

$64.3 (161.96%)

96

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MLTX (MoonLake Immunotherapeutics) average time for price targets to be met?

On average it took 45.89 days on average for the stock forecasts to be realized with a an average price target met ratio 20.09

Which analyst has the current highest performing score on MLTX (MoonLake Immunotherapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on MLTX (MoonLake Immunotherapeutics) with a proven track record?

RICHARD LAW

Which analyst has the most public recommendations on MLTX (MoonLake Immunotherapeutics)?

Raghuram Selvaraju has 3 price targets and 18 ratings on MLTX

Which analyst is the currently most bullish on MLTX (MoonLake Immunotherapeutics)?

Andreas Argyrides with highest potential upside - $51.38

Which analyst is the currently most reserved on MLTX (MoonLake Immunotherapeutics)?

Prakhar Agrawal with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?